CME INFORMATION

Video highlights from a symposium entitled
A New Paradigm in Quality Management of Venous Thromboembolism
March 16, 2005, New Orleans, Louisiana

Release date: May 26, 2005
Expiration date: May 26, 2007
Estimated time to complete activity: 1.5 hours

HARDWARE AND SOFTWARE SPECIFICATIONS NEEDED TO VIEW

The course requires Windows Operating Systems (95/98, NT, 2000, ME, XP), version 5.5 browsers or higher from Microsoft or Netscape. Certain activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Macromedia Flash, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, and Real Networks Real One Player.

ACCREDITATION STATEMENT

Medical Education Resources, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.

FACULTY DISCLOSURES

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards and the policy of Medical Education Resources, Inc., the following faculty have indicated that they have a relationship which, in the context of their presentation, could be perceived as a real or apparent conflict of interest, but do not consider that it will influence their presentation.  The nature of the conflict is listed.   Faculty Member Commercial Interest Nature of Relevant Financial Relationship (Include all those that apply) What was Received For What Role? Jack E. Ansell, MD The sanofi-aventis Group Grants, Honorarium Grants/Research Support, Speaker’s Bureau James B. Groce III, PharmD, CACP Bristol-Myers Squibb, Diagnostica Stago, Organon Teknika, Pharmacia, PharmaNetics, The sanofi-aventis Group, University Pharmacotherapy Associates Grants, Consultant Fee, Honorarium Grants/Research Support, Consulting, Honoraria, Speakers Bureau Victor F. Tapson, MD The sanofi-aventis Group Grants, Consultant Fee Grants/Research Support, Consultant

INFORMATION ON CME CREDIT

Medical Education Resources, Inc. designates this educational activity for a maximum of 1.5 category 1 credits toward the AMA Physician's Recognition Award.  Each physician should claim only those credits that he/she actually spent in the activity. This CME activity was planned and produced in accordance with the ACCME Essentials.

FINANCIAL SUPPORT

This CME activity is sponsored by Medical Education Resources, Inc. and supported by an unrestricted educational grant from sanofi-aventis U.S.

INTENDED AUDIENCE

This activity is intended for medical directors, clinicians, and pharmacists involved in long-term care.

GOAL OF THE ACTIVITY

Through completion of this activity, participants will consider the current crisis in the treatment of venous thromboembolism, the value of VTE prophylaxis, and the impact of recent recommendations from the American College of Chest Physicians (ACCP) and the Joint Commission on Accreditation of Healthcare Organizations (JCAHO).

EDUCATIONAL OBJECTIVES

Upon completion of this activity, participants will be able to: Discuss the pathophysiology and epidemiology of VTE List characteristics that put patients at high risk for VTE Discuss issues of patient selection, safety and efficacy in using antithrombotic regimens Describe recommendations recently put forth by the ACCP and JCAHO and their impact on VTE prevention and treatment Discuss pharmacoeconomic issues involved in management of VTE

UNAPPROVED USE DISCLOSURE

Medical Education Resources, Inc. requires CME faculty (speakers) to disclose to the attendees: When products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and Any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty may discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling.  This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications.  If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

At a symposium held at the American Medical Directors Association 2005 Annual Meeting in New Orleans, experts met to discuss prophylaxis in long-term care patients at risk for venous thromboembolism, or VTE. Presentations included the epidemiology of VTE (Victor Tapson); patient selection, safety, and efficacy of VTE prophylaxis (Jack Ansell); and cost-benefit issues involved in the management of VTE (James Groce). Topics addressed were relevant to a broad range of specialists, including medical directors, clinicians, and pharmacists involved in the long-term care setting.

View Entire Self-study Activity

Venous Thromboembolism
(Victor F. Tapson)

The Challenges of Venous Thromboembolism
(Jack Ansell)

VTE: Unraveling Cost-Benefit Issues
(James B. Groce)